A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : EBNA1 / EBV nuclear antigen 1

[Related PubMed/MEDLINE]
Total Number of Papers: 81
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   EBNA1  (>> Co-occurring Abbreviation)
Long Form:   EBV nuclear antigen 1
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Mechanisms of Epstein-Barr virus nuclear antigen 1 favor Tregs accumulation in nasopharyngeal carcinoma. EBV, NPC
2019 GAP31 from an ancient medicinal plant exhibits anti-viral activity through targeting to Epstein-Barr virus nuclear antigen 1. EBV, rGAP31
2019 Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk. ANO2, EBV, MS, OR
2019 The interaction between Vav1 and EBNA1 promotes survival of Burkitt's lymphoma cells by down-regulating the expression of Bim. BL, EBV, GEF
2019 The sequence analysis of Epstein-Barr virus EBNA1 gene: could viral screening markers for nasopharyngeal carcinoma be identified? EBV, NPC, UCNT
2018 Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter. EBV, NPC, Qp, Sp1
2018 Lymphomas driven by Epstein-Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2. EBV
2018 Novel Pyrrole-Imidazole Polyamide Hoechst Conjugate Suppresses Epstein-Barr Virus Replication and Virus-Positive Tumor Growth. EBV, oriP
2018 Triptolide inhibits Epstein-Barr nuclear antigen 1 expression by increasing sensitivity of mitochondria apoptosis of nasopharyngeal carcinoma cells. EBV, NPC
10  2017 Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis. CMV, EBV, RRMS, VCA, VZV
11  2017 Latent Membrane Protein 1 Is a Novel Determinant of Epstein-Barr Virus Genome Persistence and Reactivation. ALI, EBV, LMP1, NPC
12  2017 Novel Epstein-Barr virus-like particles incorporating gH/gL-EBNA1 or gB-LMP2 induce high neutralizing antibody titers and EBV-specific T-cell responses in immunized mice. EBV, LMP2, VLP
13  2016 Characterization of the Variability of Epstein-Barr Virus Genes in Nasopharyngeal Biopsies: Potential Predictors for Carcinoma Progression. EBV, LMP1, UCNT
14  2016 Epstein-Barr Virus Infection in Gastric Remnant Carcinoma and Recurrent Gastric Carcinoma in Qingdao of Northern China. CGC, EBER, EBV, EBVaGC, GRC, LMP1, RGC
15  2016 The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma. cHL, EBV, LMP
16  2015 Detection of nasopharyngeal carcinoma in Morocco (North Africa) using a multiplex methylation-specific PCR biomarker assay. DNA, EBV, LMP1, MMSP, NPC, TSGs
17  2015 Modulation of MicroRNA Cluster miR-183-96-182 Expression by Epstein-Barr Virus Latent Membrane Protein 1. BL, EBERs, EBV, LMP1, miR-BART, miRNAs, RT-PCR, TGF-beta1
18  2015 Reduced Transplacental Transfer of a Subset of Epstein-Barr Virus-Specific Antibodies to Neonates of Mothers Infected with Plasmodium falciparum Malaria during Pregnancy. EAd, EBV, VCA, Zta
19  2014 Epstein-Barr virus nuclear antigen 1 (EBNA1) protein induction of epithelial-mesenchymal transition in nasopharyngeal carcinoma cells. EBV, EMT, miR-200a, NPC, ZEB1
20  2014 Functional analysis and molecular characterization of spontaneously outgrown human lymphoblastoid cell lines. EBV, LCL, RBMS1
21  2013 Association of Epstein-Barr virus infection with multiple sclerosis in India. EBV, ELISA, HLA, IgG, MS
22  2013 Characterization of naturally Epstein-Barr virus-infected gastric carcinoma cell line YCCEL1. EBV, LMP2A, miRNAs
23  2013 Constitutive interferon-inducible protein 16-inflammasome activation during Epstein-Barr virus latency I, II, and III in B and epithelial cells. EBERs, EBV, FISH, IFI16, IL-1beta, LCL, NPC
24  2013 Phase I trial of recombinant modified vaccinia ankara encoding Epstein-Barr viral tumor antigens in nasopharyngeal carcinoma patients. EBV, LMP2, PFU
25  2013 Robust T-cell stimulation by Epstein-Barr virus-transformed B cells after antigen targeting to DEC-205. DCs, EBV, LCLs, LMP1
26  2012 Age at Epstein-Barr virus infection and Epstein-Barr virus nuclear antigen-1 antibodies in Swedish children. Ab, EBV, IM, MS
27  2012 EBV-specific immune responses in patients with multiple sclerosis responding to IFNbeta therapy. EBV, HCMV, IFN-beta, MS
28  2012 Effective treatment of metastatic forms of Epstein-Barr virus-associated nasopharyngeal carcinoma with a novel adenovirus-based adoptive immunotherapy. EBV, NPC
29  2012 Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer. EBV, PCR, siRNA, ZEB1
30  2011 alpha-1-antitrypsin gene delivery reduces inflammation, increases T-regulatory cell population size and prevents islet allograft rejection. CIA, EAE, EBV, hAAT, LPS, Treg
31  2011 Epstein-Barr virus nuclear antigen 1 replication and segregation functions in nasopharyngeal carcinoma cell lines. EBV, NPC
32  2011 Non-integrating lentiviral vectors for specific killing of Epstein-Barr virus nuclear antigen 1-positive B cell lymphoma cells. EBV, FR, NILV, TK
33  2011 Novel mouse xenograft models reveal a critical role of CD4+ T cells in the proliferation of EBV-infected T and NK cells. CAEBV, EBV, EBV-HLH, LMP1
34  2011 Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC families. EBV, NPC, ROC, VCA
35  2010 Expansion of EBNA1-specific effector T cells in posttransplantation lymphoproliferative disorders. EBV
36  2010 FR-like EBNA1 binding repeats in the human genome. EBV
37  2010 Hsp90 inhibitors block outgrowth of EBV-infected malignant cells in vitro and in vivo through an EBNA1-dependent mechanism. ---
38  2009 Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis. EBV, IgG, LCL, MS, PBMC
39  2009 EBNA1 regulates cellular gene expression by binding cellular promoters. BL, EBV
40  2009 Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis. EBER-1, EBV, GSEA, NPC, NPE
41  2009 Phosphorylation sites of Epstein-Barr virus EBNA1 regulate its function. EBV
42  2009 Robust in vivo transduction of a genetically stable Epstein-Barr virus episome to hepatocytes in mice by a hybrid viral vector. EBV, HDAd
43  2009 Role for G-quadruplex RNA binding by Epstein-Barr virus nuclear antigen 1 in DNA replication and metaphase chromosome attachment. EBV, LR1, ORC
44  2009 [Evaluation of combined determinations of Epstein-Barr virus antibodies for nasopharyngeal carcinoma assessed with receiver operating characteristic curve based on logistic regression]. AUC, EA, EBV, ELISA, Ig, NPC, ROC, VCA
45  2008 Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus. BAC, EBV, LCLs
46  2008 EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. EBV, MS, Th1
47  2008 Epstein-Barr virus genetic variation in Vietnamese patients with nasopharyngeal carcinoma: full-length analysis of LMP1. EBV, NPC
48  2008 Evaluation of a multianalyte profiling assay and an enzyme-linked immunosorbent assay for serological examination of Epstein-Barr virus-specific antibody responses in diagnosis of nasopharyngeal carcinoma. EBV, ELISA, IgA, NPC, VCA
49  2007 Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing. CR, CTL, HHV-8, LANA1
50  2006 Establishment and applications of epstein-barr virus-based episomal vectors in human embryonic stem cells. EBV, EGFP, hES
51  2006 Infection of Epstein-Barr virus in colorectal cancer in Chinese. EBERs, EBV, LMP1, PCR
52  2006 Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt's lymphoma cells. EBV, RNAi, shRNAs
53  2006 Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes. ---
54  2005 Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis. BLs, EBNA2, EBV, Wp
55  2004 The amino terminus of Epstein-Barr Virus (EBV) nuclear antigen 1 contains AT hooks that facilitate the replication and partitioning of latent EBV genomes by tethering them to cellular chromosomes. EBV
56  2003 Contrasting roles of dendritic cells and B cells in the immune control of Epstein-Barr virus. EBV
57  2003 Gamma herpesviruses: pathogenesis of infection and cell signaling. IE, LANA1, vFLIP
58  2003 Primary nasopharyngeal non-Hodgkin lymphoma and its relationship with Epstein-Barr virus infection. EBERs, EBV, LMP1, LMP2A, MA, NPL, VCA
59  2003 The B subunit of Escherichia coli heat-labile enterotoxin enhances CD8+ cytotoxic-T-lymphocyte killing of Epstein-Barr virus-infected cell lines. CTLs, EBV, EtxB, LCLs, LMPs
60  2003 The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold. EBV, LCL, SCID
61  2003 Unique Epstein-Barr virus (EBV) latent gene expression, EBNA promoter usage and EBNA promoter methylation status in chronic active EBV infection. CAEBV, EBV
62  2002 Lack of expression of the Epstein-Barr Virus (EBV) gene products, EBERs, EBNA1, LMP1, and LMP2A, in breast cancer cells. EBV
63  2002 Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex. CTL, EBV, IFN, IL, NK
64  2002 Successful genetic transduction in vivo into synovium by means of electroporation. EBV, EGFP, pDNA
65  2001 Activity of the EBNA1 promoter associated with lytic replication (Fp) in Epstein-Barr virus associated disorders. EBV
66  2001 Epstein-Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growth. EBV
67  2001 Establishment of latent Epstein-Barr virus infection and stable episomal maintenance in murine B-cell lines. EBV
68  2001 Highly efficient gene transfer into murine liver achieved by intravenous administration of naked Epstein-Barr virus (EBV)-based plasmid vectors. EBV, pDNA
69  2000 Effective suicide gene therapy in vivo by EBV-based plasmid vector coupled with polyamidoamine dendrimer. EBV, GCV, HCC, PAMAM, SCID
70  2000 Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors. EBV, HD, LMP1
71  1999 Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1. CTL, EBV, GAr, LCV
72  1998 Epstein-Barr-virus-infected human T-cell line with a unique pattern of viral-gene expression. EBER1, EBV, LMP1
73  1998 Nucleic acid sequence-based amplification, a new method for analysis of spliced and unspliced Epstein-Barr virus latent transcripts, and its comparison with reverse transcriptase PCR. BARF1, EBER1, EBV, HD, LMP, NASBA, NPC, RT
74  1997 Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas. AIDS, EBV
75  1997 [Isolation and characterization of Epstein-Barr virus-infected clones of a human T-lymphoblastoid cell line]. EBV, LMP1
76  1996 Epstein-Barr Virus DNA recombination and loss in sporadic Burkitt's lymphoma. EBV
77  1996 [Latency of Epstein-Barr virus and its relationship to nasopharyngeal carcinomas]. EBV, LMP, NPC
78  1995 Improved expression cloning using reporter genes and Epstein-Barr virus ori-containing vectors. AT1, beta-Gal, EBV
79  1992 The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle. EBV, LCLs
80  1989 Epstein-Barr virus gene expression in malignant lymphomas induced by experimental virus infection of cottontop tamarins. EBV, LMP
81  1988 Characterization of a latent protein encoded by the large internal repeats and the BamHI Y fragment of the Epstein-Barr virus (EBV) genome. EBV